Recombinant Human IRGM Protein ，GST

IRGM (Immunity Related GTPase M) is a crucial protein involved in the immune response and autophagy regulation, specifically in the context of host defense against intracellular pathogens. Research into IRGM has intensified due to its association with various diseases, including Crohn's disease and tuberculosis. Mutations and polymorphisms in the IRGM gene can influence susceptibility to these conditions by affecting the protein's function in the immune system. IRGM’s role in autophagy—where it aids in the degradation of pathogens—highlights its importance in maintaining cellular homeostasis. As the understanding of IRGM’s mechanisms deepens, scientists have increasingly focused on developing recombinant IRGM proteins for experimental applications. These studies aim to explore its structure, function, and interactions with other cellular components. By utilizing recombinant DNA technologies, researchers can produce IRGM in controlled laboratory settings, facilitating detailed biochemical analyses and functional assays. This work is essential for elucidating the pathways regulated by IRGM and for developing potential therapeutic strategies that target its pathways in diseases where it plays a significant role. Overall, the investigation of recombinant IRGM proteins is a pivotal aspect of current immunology research, with implications for understanding disease mechanisms and advancing therapeutic interventions.